代用皮膚の世界市場：タイプ別、使用別、組成別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界の代用皮膚の市場規模は、2023年に3億5,663万米ドルと評価され、2031年には6億8,126万米ドルに達すると予測されており、2024年から2031年の予測期間のCAGRは8.43%になるとみられています。世界の代用皮膚市場を牽引している主な要因には、慢性創傷の増加、代用皮膚技術の進歩、火傷や外傷の増加、皮膚関連の懸念に脆弱な高齢者層の拡大などがあります。さらに、市場の成長は、美容治療に対する需要と、皮膚損傷に直面している人々の幸福を改善するための努力によって増強されています。

世界の代用皮膚市場は、糖尿病や血管疾患のような生活習慣病と関連することが多い慢性創傷の有病率の上昇により大きな牽引力を得ており、創傷治癒のための革新的なソリューションが必要とされているため、代用皮膚製品に対する需要を刺激しています。代用皮膚技術の進歩も重要な要因です。継続的な研究開発の努力により、より洗練された天然の皮膚に似せた代用品が開発されています。これらの進歩は、様々な傷や怪我の治療効果を著しく向上させ、世界の代用皮膚市場の成長をさらに後押ししています。

さらに、火傷や外傷の世界の急増により、高度な創傷治療ソリューションの必要性が高まっており、世界の代用皮膚市場における代用皮膚の需要をさらに促進しています。さらに、褥瘡や慢性創傷など皮膚に関連した問題を抱えやすい高齢者人口の増加は、これらの懸念に対処するために設計された代用皮膚の市場拡大をもたらしています。医療必需品だけでなく、代用皮膚が重要な役割を果たす美容治療市場も拡大しています。皮膚の質感や外観を改善するための美容施術に組み込まれることが増えており、美的改善を求める個人を対象としています。要するに、世界の代用皮膚市場の拡大は、医療上の必要性と、皮膚の損傷を抱える人々の生活の質を向上させるという集団的な重点によって推進されています。これは、幸福感を高め、回復を助けるという代用皮膚の極めて重要な役割を強調しています。

当レポートでは、世界の代用皮膚市場について調査し、市場の概要とともに、タイプ別、使用別、組成別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の代用皮膚市場の見通し、2017年～2031年

• 市場規模と予測
• タイプ別
• 使用別
• 組成別
• 用途別
• エンドユーザー別
• 地域別
• 企業別市場シェア（%）、2023年

第5章 世界の代用皮膚市場の見通し、地域別、2017年～2031年

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Acelity L.P., Inc.
• Scapa Healthcare
• Johnson & Johnson Services, Inc.
• Paul Hartmann AG
• Molnlycke Health Care AB
• Essity Health & Medical
• Medtronic plc
• Coloplast Corp.
• Smith & Nephew plc
• Convatec Group plc
• Organogenesis Holdings Inc.
• 3M Health Care
• Integra LifeSciences Corporation

第14章 戦略的提言

第15章 お問合せと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 2. Global Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 3. Global Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 4. Global Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 5. Global Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 6. Global Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 7. Global Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 8. Global Skin Substitutes Market Share (%), By Region, 2017-2031F
• Figure 9. North America Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 10. North America Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 11. North America Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 12. North America Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 13. North America Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 14. North America Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 15. North America Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 16. North America Skin Substitutes Market Share (%), By Country, 2017-2031F
• Figure 17. United States Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 18. United States Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 19. United States Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 20. United States Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 21. United States Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 22. United States Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 23. United States Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 24. Canada Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 25. Canada Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 26. Canada Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 27. Canada Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 28. Canada Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 29. Canada Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 30. Canada Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 31. Mexico Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 32. Mexico Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 33. Mexico Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 34. Mexico Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 35. Mexico Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 36. Mexico Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 37. Mexico Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 38. Europe Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 39. Europe Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 40. Europe Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 41. Europe Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 42. Europe Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 43. Europe Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 44. Europe Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 45. Europe Skin Substitutes Market Share (%), By Country, 2017-2031F
• Figure 46. Germany Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 47. Germany Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 48. Germany Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 49. Germany Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 50. Germany Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 51. Germany Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 52. Germany Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 53. France Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 54. France Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 55. France Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 56. France Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 57. France Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 58. France Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 59. France Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 60. Italy Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 61. Italy Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 62. Italy Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 63. Italy Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 64. Italy Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 65. Italy Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 66. Italy Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 67. United Kingdom Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 68. United Kingdom Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 69. United Kingdom Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 70. United Kingdom Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 71. United Kingdom Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 72. United Kingdom Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 73. United Kingdom Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 74. Russia Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 75. Russia Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 76. Russia Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 77. Russia Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 78. Russia Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 79. Russia Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 80. Russia Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 81. Netherlands Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 82. Netherlands Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 83. Netherlands Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 84. Netherlands Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 85. Netherlands Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 86. Netherlands Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 87. Netherlands Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 88. Spain Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 89. Spain Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 90. Spain Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 91. Spain Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 92. Spain Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 93. Spain Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 94. Spain Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 95. Turkey Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 96. Turkey Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 97. Turkey Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 98. Turkey Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 99. Turkey Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 100. Turkey Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 101. Turkey Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 102. Poland Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 103. Poland Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 104. Poland Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 105. Poland Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 106. Poland Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 107. Poland Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 108. Poland Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 109. South America Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 110. South America Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 111. South America Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 112. South America Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 113. South America Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 114. South America Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 115. South America Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 116. South America Skin Substitutes Market Share (%), By Country, 2017-2031F
• Figure 117. Brazil Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 118. Brazil Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 119. Brazil Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 120. Brazil Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 121. Brazil Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 122. Brazil Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 123. Brazil Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 124. Argentina Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 125. Argentina Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 126. Argentina Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 127. Argentina Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 128. Argentina Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 129. Argentina Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 130. Argentina Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 131. Asia-Pacific Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 132. Asia-Pacific Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 133. Asia-Pacific Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 134. Asia-Pacific Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 135. Asia-Pacific Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 136. Asia-Pacific Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 137. Asia- Pacific Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 138. Asia-Pacific Skin Substitutes Market Share (%), By Country, 2017-2031F
• Figure 139. India Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 140. India Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 141. India Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 142. India Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 143. India Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 144. India Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 145. India Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 146. China Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 147. China Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 148. China Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 149. China Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 150. China Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 151. China Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 152. China Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 153. Japan Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 154. Japan Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 155. Japan Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 156. Japan Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 157. Japan Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 158. Japan Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 159. Japan Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 160. Australia Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 161. Australia Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 162. Australia Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 163. Australia Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 164. Australia Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 165. Australia Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 166. Australia Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 167. Vietnam Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 168. Vietnam Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 169. Vietnam Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 170. Vietnam Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 171. Vietnam Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 172. Vietnam Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 173. Vietnam Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 174. South Korea Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 175. South Korea Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 176. South Korea Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 177. South Korea Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 178. South Korea Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 179. South Korea Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 180. South Korea Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 181. Indonesia Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 182. Indonesia Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 183. Indonesia Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 184. Indonesia Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 185. Indonesia Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 186. Indonesia Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 187. Indonesia Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 188. Philippines Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 189. Philippines Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 190. Philippines Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 191. Philippines Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 192. Philippines Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 193. Philippines Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 194. Philippines Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 195. Middle East & Africa Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 196. Middle East & Africa Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 197. Middle East & Africa Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 198. Middle East & Africa Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 199. Middle East & Africa Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 200. Middle East & Africa Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 201. Middle East & Africa Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 202. Middle East & Africa Skin Substitutes Market Share (%), By Country, 2017-2031F
• Figure 203. Saudi Arabia Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 204. Saudi Arabia Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 205. Saudi Arabia Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 206. Saudi Arabia Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 207. Saudi Arabia Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 208. Saudi Arabia Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 209. Saudi Arabia Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 210. UAE Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 211. UAE Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 212. UAE Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 213. UAE Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 214. UAE Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 215. UAE Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 216. UAE Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 217. South Africa Skin Substitutes Market, By Value, In USD Million, 2017-2031F
• Figure 218. South Africa Skin Substitutes Market, By Volume, In Millions, 2017-2031F
• Figure 219. South Africa Skin Substitutes Market Share (%), By Type, 2017-2031F
• Figure 220. South Africa Skin Substitutes Market Share (%), By Use, 2017-2031F
• Figure 221. South Africa Skin Substitutes Market Share (%), By Composition, 2017-2031F
• Figure 222. South Africa Skin Substitutes Market Share (%), By Application, 2017-2031F
• Figure 223. South Africa Skin Substitutes Market Share (%), By End-user, 2017-2031F
• Figure 224. By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 225. By Use Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 226. By Composition Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 227. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 228. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 229. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global skin substitutes market size was valued at USD 356.63 million in 2023, which is expected to reach USD 681.26 million in 2031, with a CAGR of 8.43% for the forecast period between 2024 and 2031F. The main forces propelling the global skin substitutes market include the rising occurrence of chronic wounds, advancements in skin substitute technologies, a rise in burn and trauma cases, and expanding elderly demographic vulnerable to skin-related concerns. Moreover, the market's growth is augmented by the demand for aesthetic treatments and efforts to improve the well-being of individuals facing skin injuries.

The global skin substitutes market is gaining significant traction due to the increasing prevalence of chronic wounds, often linked to lifestyle-related ailments like diabetes and vascular diseases, necessitating innovative solutions for wound healing, thereby stimulating the demand for skin substitute products. Advancements in skin substitute technologies stand as another crucial factor. Ongoing research and development endeavors have led to the development of more sophisticated and natural skin-mimicking substitutes. These advancements significantly enhance the efficacy of treating various wounds and injuries, thereby further boosting the growth of the global skin substitutes market.

Moreover, the global surge in burn and trauma cases has intensified the need for advanced wound care solutions, further fueling the demand for skin substitutes in the global skin substitutes market. Additionally, the growing elderly population, prone to skin-related issues such as pressure ulcers and chronic wounds, presents an expanding market for skin substitutes designed to address these concerns. Beyond medical necessities, there's a growing market for aesthetic treatments, where skin substitutes play a significant role. They are increasingly incorporated into cosmetic procedures to improve skin texture and appearance, catering to individuals seeking aesthetic improvements. In essence, the expansion of the global skin substitutes market is driven by medical requirements and collective emphasis on improving the quality of life for individuals dealing with skin injuries. It underscores the pivotal role of skin substitutes in augmenting well-being and aiding recovery.

Surge in Burn and Trauma Cases

The surge in global burn and trauma cases significantly propels the expansion of the global skin substitutes market. These incidents arise from various causes, such as accidents, industrial mishaps, conflicts, and natural calamities, necessitating advanced wound care solutions for diverse and severe skin injuries. In this context, skin substitutes serve a crucial role, offering innovative treatment avenues that accelerate wound healing, minimize infection risks, and mitigate scarring. The increasing demand for improved patient care has led to a widespread adoption of skin substitutes in medical settings, driving substantial market growth. The trend underscores the continual need for advancements in skin substitute technologies to cater to the evolving needs of individuals worldwide grappling with burns and traumatic injuries.

New Age Technologies

Advancements in technology, particularly the incorporation of 3D printing, profoundly impact the growth of the global skin substitutes market. Through 3D printing, intricate and adaptable skin substitutes, replicating natural skin qualities, can be crafted. The technological breakthrough transforms manufacturing methods by providing exact regulation over the substitute's makeup and design. These technological strides improve treatment effectiveness, accelerating healing processes, and decreasing rejection probabilities. Hence, the integration of 3D printing technology propels the market forward, providing sophisticated, tailored solutions that address the varying requirements of individuals dealing with skin injuries or ailments. As an example, on December 8, 2023, Grupo Boticario from Brazil revealed the successful creation of 3D skin through bioprinting innovation. Termed a pioneering achievement globally, the initiative involves crafting a specific type of skin utilizing bioprinting technology. The technique involves blending cells with bioinks and biomaterials, followed by 3D printing to produce functional living tissue models.

Government Initiatives

Governments worldwide are proactively engaging in partnerships with private businesses to stimulate growth in the global skin substitutes market. These collaborations involve financing research and development, endorsing groundbreaking technologies, and optimizing regulatory processes for faster product clearance. Through these public-private alliances, governments seek to increase market strength by enabling resource accessibility, encouraging innovation, and advancing the availability of sophisticated skin substitute products. These strategic unions between governmental bodies and private sectors act as accelerators, driving skin substitutes' evolution and expansion to meet escalating healthcare and aesthetic needs. For example, India's Lovell Government Services and BioStem Technologies revealed in September 2023 that they have successfully enrolled BioStem on crucial government contract platforms. As a result, government clients got access to BioStem's assortment of placental-based tissue allografts for advanced wound care through various channels, including the Department of Defense's Distribution and Pricing Agreement (DAPA), the Department of Veterans Affairs Federal Supply Schedule (FSS), and the Defense Logistics Agency's ECAT system. This inclusion was facilitated by Lovell Government Services, BioStem's exclusive partner, and a Service-Disabled Veteran-Owned Small Business (SDVOSB).

Rising Demand for Cellular Allografts

The rising need for cellular allografts significantly propels the growth of the global skin substitutes market. These allografts, sourced from human tissues, provide a flexible remedy for diverse wound categories. Their distinct makeup, containing live cells and biological elements, expedite healing by prompting tissue renewal. The demand escalates as healthcare professionals increasingly acknowledge the effectiveness of cellular allografts in managing intricate wounds. The increased demand notably aids in expanding the skin substitutes market, driving innovation and creating sophisticated cellular-based products to cater to the changing requirements of patients seeking wound care. For instance, in January 2023, Epifix, a placental tissue allograft manufactured by Purion, was introduced to the Japanese market by MiMedx Group, Inc., in collaboration with Gunze Medical. With more than 300 regulatory proteins, Epifix provides a human biocompatible extracellular matrix and functions as a barrier to protect wounds from healing. The partnership aims to increase revenue, broaden the company's customer base, and increase its geographic reach.

Treatment of Chronic Diseases

The extensive adoption of skin substitutes to treat chronic diseases notably drives the global skin substitutes market. These alternatives offer effective remedies for conditions such as diabetic ulcers and venous insufficiency ulcers. By facilitating wound closure and creating an environment conducive to tissue regeneration, they accelerate the healing process. As their effectiveness in managing chronic wounds gains wider acknowledgment, the demand for these substitutes increases significantly. The amplified utilization expands the market and spur ongoing innovation, encouraging the creation of highly specialized and advanced skin substitute products customized to cater to the specific requirements of patients with chronic conditions. For instance, during April 2023, Kerecis, a medical company specializing in fish skin, introduced the MariGen Shield. The innovation merges the company's fish-skin graft with a silicone contact layer to address chronic and intricate wounds. The new product features fenestrations that facilitate the proper drainage of wounds, establishing an optimal environment for wound care. Moreover, it maintains ideal moisture levels essential for fostering efficient healing processes.

Future Market Scenario

The prospects of global skin substitutes market showcase exceptional promise and dynamism. The positive outlook stems from various contributing factors. Ongoing technological advancements continue to transform the sector by introducing novel materials and manufacturing methods, like bioprinting and refined formulations, that better emulate natural skin properties. These advancements enable the creation of more efficient, tailor-made skin substitutes that cater to diverse patient requirements. Additionally, the increasing prevalence of chronic illnesses and injuries globally bodes well for market expansion. With aging populations and a rise in chronic wound cases, there's a growing demand for advanced wound care solutions, further stimulating the market growth. Moreover, collaborative initiatives involving governments, research institutions, and private entities drive constant innovation and regulatory support, hastening product advancements and market reach. In essence, the amalgamation of technological progress, expanding healthcare needs, and collaborative initiatives sets a promising stage for the global skin substitutes market, offering a positive outlook for improved wound treatment and better patient outcomes.

Key Players Landscape and Outlook

Prominent companies in the global skin substitutes market actively engage in mergers and acquisitions to strengthen their competitive advantage and broaden their market footprint. Through strategic consolidation, these leading firms strive to harness synergies, expand their range of products, and gain access to new technologies or unique solutions. By acquiring businesses that complement their operations or merging with compatible entities, the companies aim to boost their research capabilities, streamline production processes, and enter untapped markets. The strategic moves empower these major players to pool resources, take advantage of economies of scale, and ultimately deliver innovative, high-quality skin substitutes, solidifying their standing as leaders in the industry. For example, in July 2023, Coloplast, a Danish medical products company, disclosed its intention to purchase Kerecis, an Icelandic biologics wound-care company renowned for utilizing fish skins in wound healing. The agreement, valued at a potential sum of USD 1.3 billion, includes an initial cash payment of USD 1.2 billion. Coloplast highlighted in a statement that this acquisition is set to bolster its position in the wound-care industry, particularly by establishing a foothold in the United States market segment.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Skin Substitutes Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. Value
  • 4.1.2. Volume
• 4.2. By Type
  • 4.2.1. Biological
  • 4.2.2. Synthetic
  • 4.2.3. Biosynthetic
• 4.3. By Use
  • 4.3.1. Temporary
  • 4.3.2. Permanent
• 4.4. By Composition
  • 4.4.1. Amnion
  • 4.4.2. Cultured Epithelial Autograft
  • 4.4.3. Acellular Allograft
  • 4.4.4. Cellular Allograft
  • 4.4.5. Xenografts
  • 4.4.6. Composites
  • 4.4.7. Synthetics
• 4.5. By Application
  • 5.4.1. Acute Wounds
  • 5.4.2. Chronic Wounds
  • 5.4.3. Others
• 4.6. By End-user
  • 4.6.1. Hospital
  • 4.6.2. Specialty Clinics
  • 4.6.3. Ambulatory Surgical Centers
  • 4.6.4. Research Laboratory
• 4.7. By Region
  • 4.7.1. North America
  • 4.7.2. Europe
  • 4.7.3. South America
  • 4.7.4. Asia-Pacific
  • 4.7.5. Middle East and Africa
• 4.8. By Company Market Share (%), 2023

5. Global Skin Substitutes Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. Value
    • 5.1.1.2. Volume
  • 5.1.2. By Type
    • 5.1.2.1. Biological
    • 5.1.2.2. Synthetic
    • 5.1.2.3. Biosynthetic
  • 5.1.3. By Use
    • 5.1.3.1. Temporary
    • 5.1.3.2. Permanent
  • 5.1.4. By Composition
    • 5.1.4.1. Amnion
    • 5.1.4.2. Cultured Epithelial Autograft
    • 5.1.4.3. Acellular Allograft
    • 5.1.4.4. Cellular Allograft
    • 5.1.4.5. Xenografts
    • 5.1.4.6. Composites
    • 5.1.4.7. Synthetics
  • 5.1.5. By Application
    • 5.1.5.1. Acute Wounds
    • 5.1.5.2. Chronic Wounds
    • 5.1.5.3. Others
  • 5.1.6. By End-user
    • 5.1.6.1. Hospital
    • 5.1.6.2. Specialty Clinics
    • 5.1.6.3. Ambulatory Surgical Centers
    • 5.1.6.4. Research Laboratory
  • 5.1.7. United States*
    • 5.1.7.1. Market Size & Forecast
    • 5.1.7.1.1. Value
    • 5.1.7.1.2. Volume
    • 5.1.7.2. By Type
    • 5.1.7.2.1. Biological
    • 5.1.7.2.2. Synthetic
    • 5.1.7.2.3. Biosynthetic
    • 5.1.7.3. By Use
    • 5.1.7.3.1. Temporary
    • 5.1.7.3.2. Permanent
    • 5.1.7.4. By Composition
    • 5.1.7.4.1. Amnion
    • 5.1.7.4.2. Cultured Epithelial Autograft
    • 5.1.7.4.3. Acellular Allograft
    • 5.1.7.4.4. Cellular Allograft
    • 5.1.7.4.5. Xenografts
    • 5.1.7.4.6. Composites
    • 5.1.7.4.7. Synthetics
    • 5.1.7.5. By Application
    • 5.1.7.5.1. Acute Wounds
    • 5.1.7.5.2. Chronic Wounds
    • 5.1.7.5.3. Others
    • 5.1.7.6. By End-user
    • 5.1.7.6.1. Hospital
    • 5.1.7.6.2. Specialty Clinics
    • 5.1.7.6.3. Ambulatory Surgical Centers
    • 5.1.7.6.4. Research Laboratory
  • 5.1.8. Canada
  • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. South America
  • 5.3.1. Brazil
  • 5.3.2. Argentina
• 5.4. Asia Pacific
  • 5.4.1. India
  • 5.4.2. China
  • 5.4.3. Japan
  • 5.4.4. Australia
  • 5.4.5. Vietnam
  • 5.4.6. South Korea
  • 5.4.7. Indonesia
  • 5.4.8. Philippines
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Type
• 6.2. By Use
• 6.3. By Composition
• 6.4. By Application
• 6.5. By End-user
• 6.6. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Acelity L.P., Inc.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Scapa Healthcare
• 13.3. Johnson & Johnson Services, Inc.
• 13.4. Paul Hartmann AG
• 13.5. Molnlycke Health Care AB
• 13.6. Essity Health & Medical
• 13.7. Medtronic plc
• 13.8. Coloplast Corp.
• 13.9. Smith & Nephew plc
• 13.10. Convatec Group plc
• 13.11. Organogenesis Holdings Inc.
• 13.12. 3M Health Care
• 13.13. Integra LifeSciences Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer